How Independent Pharmacies Are Combatting the Opioid Crisis
Pharmacists are uniquely poised to combat the opioid crisis. Here's what pharmacists (and Congress) can do about it.
View ArticleDIR Fees, Medical Marijuana Among Hot Topics at NCPA Convention
What you need to know about the upcoming NCPA convention.
View ArticleHigh-Alert Medications
High-alert drugs pose a significant threat to patient safety. There are safeguards that pharmacists should put in place to reduce the risk.
View ArticleGenoa MMS: Medication Management for its Community Pharmacies
Two groups are joining forces to enhance medication management.
View ArticleFDA Plans to Expand Access to Certain Opioids
Commissioner Scott Gottlieb makes departure from previous policy.
View ArticlePharmacist Sentenced to Prison for Oxycodone Scheme
The scheme made him hundreds of thousands of dollars—and prison time.
View ArticleCommunity Pharmacists Praise New Opioid Measures
In the war against the opioid epidemic, pharmacists are excited about their seat at the table.
View ArticleHealth Apps Could Produce $7 Billion in Savings
The number of health apps is spiking, but they're also getting better.
View ArticleCompounding Pharmacy’s License Suspended
A compounding pharmacist is accused of a "gross breach of professional duty."
View ArticleOhio’s PDMP Gives Pharmacists Better Patient View
The PDMP will give pharmacists access to advanced analytics.
View ArticlePharmacy ordered to repay nearly $1 million to Medicaid
An independent community pharmacy was busted in a Medicare fraud investigation.
View ArticleASHP Celebrates 75th Anniversary at Midyear 2017
This year, pharmacists can look forward to a variety of great topics and meetings in Orlando.
View ArticleWarfarin Linked to Lower Cancer Risk
A large Norwegian cohort study has found that warfarin is associated with a reduced risk of cancer.
View ArticlePharmacies Trafficking Opioids Targeted by DEA
Operation Faux Pharmacy resulted in over half a million drugs seized.
View ArticleA Bigger Role for Pharmacists
From bioterror attacks to the opioid epidemic, pharmacists are in a great place to help.
View ArticleBiosimilars for Cancer Drugs Move Ahead
Biosimilar to Herceptin Is Approved and Neulasta biosimilar does well in studies.
View ArticleGeneric Viagra Could Save Patients Millions
Both Pfizer and Teva have brought out generic versions of Viagra, a boon to the millions of men with erectile dysfunction.
View ArticleNo Matter the Law, Pharmacists Need to Know About Cannabis
Pharmacists should take a leadership position on medical cannabis.
View ArticlePharmacists Must Weigh DOACs’ Benefits Versus Risks
Direct oral anticoagulants have expanded treatment options for patients with venous thromboembolisms, but they are not for everyone.
View ArticleProtein Shows Promise for Anticoagulation in Chronic Kidney Disease
A protein called STUB1 may help prevent blood clots in patients with chronic kidney disease without causing bleeding complications.
View ArticleFDA: Opioid Cold Meds Not Safe for Kids
The agency’s ruling also added an additional Boxed Warning.
View ArticleNew DIR Proposal Supported by Chains, Pharmacy Organizations
CMS is considering big changes to DIR fees and pharmacists are excited.
View ArticleSmall Doses: 6 Stories You Need to Know in January
Easy-to-swallow bits of information from around the world of pharmacy.
View ArticleCMS Proposes Part D Opioid Limits, Pharmacy Reacts
Pharmacy groups are praising new Medicare Part D opioid limits.
View Article
